Evidence map›Paper›PMID 38392862›Full record

ArticlePathogens (Basel, Switzerland)2024

Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC.

Elisabeth W Andersen, Paige Kulie, Amanda D Castel, Jose Lucar, Debra Benator, Alan E Greenberg, Anne Monroe, DC Cohort Executive Committee

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elisabeth W AndersenDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA.
Paige KulieDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA.ORCID 0000-0002-6250-8075
Amanda D CastelDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA.ORCID 0000-0002-9095-2413
Jose LucarDivision of Infectious Diseases, The George Washington School of Medicine and Health Sciences, Washington, DC 20052, USA.
Debra BenatorThe Washington DC Veterans Affairs Administration, Washington, DC 20422, USA.
Alan E GreenbergDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA.
Anne MonroeDepartment of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA.ORCID 0000-0003-3201-3845
DC Cohort Executive Committee
Milken Institute · USGeorge Washington University · US

Funding

The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DCR24AI152598 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Amanda Derryck Castel, Marinella Temprosa · 2020 to 2026
$37.9M
NIAID NIH HHS R24 AI152598NIH HHS R24AI152598
6 · The paper itself

Abstract

People with HIV (PWH) are disproportionally affected by mpox and at risk of severe complications. We assessed mpox knowledge, adoption of preventive behaviors, and vaccination attitudes among PWH enrolled in a longitudinal HIV cohort in Washington, DC, the DC Cohort. We conducted uni- and multivariable analyses comparing participants by vaccination status and HIV risk group, and multinomial regression to identify factors associated with vaccine acceptance. Among 430 PWH, 378 (87.9%) were aware of mpox. Among 373 participants with vaccination status data, 101 (27.1%) were vaccinated, 129 (34.6%) planned to vaccinate, and 143 (38.3%) did not plan to vaccinate. The three vaccination groups differed significantly by age, race, education, HIV risk group, recent STI status, and level of mpox worry (all

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsVaccinationAdultDistrict of ColumbiaFemaleHomosexuality, MaleHumansMaleMiddle AgedMpox, MonkeypoxPatient Acceptance of Health CareRisk Reduction BehaviorSmallpox VaccineSmallpox Vaccineawarenessbehavior changeHIVknowledgempoxrisk reductionvaccination

Identifiers

PMID38392862
PMCPMC10891655
OpenAlexW4391323138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.